187 related articles for article (PubMed ID: 31960496)
21. Success of dupilumab as a monotherapy in an adult patient affected by severe uncontrolled asthma and atopic dermatitis.
Tolino E; Proietti I; Sarni A; Bernardini N; Mambrin A; Balduzzi V; Maddalena P; Marchesiello A; Michelini S; Volpe S; Skroza N; Potenza C
Dermatol Ther; 2021 Jan; 34(1):e14596. PubMed ID: 33244860
[No Abstract] [Full Text] [Related]
22. Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry.
Ariëns LFM; van der Schaft J; Bakker DS; Balak D; Romeijn MLE; Kouwenhoven T; Kamsteeg M; Giovannone B; Drylewicz J; van Amerongen CCA; Delemarre EM; Knol EF; van Wijk F; Nierkens S; Thijs JL; Schuttelaar MLA; de Bruin-Weller MS
Allergy; 2020 Jan; 75(1):116-126. PubMed ID: 31593343
[TBL] [Abstract][Full Text] [Related]
23. Improvement of atopic dermatitis and IgA nephropathy in a patient treated by dupilumab.
Tanczosova M; Arenberger P; Rychlik I; Arenbergerova M; Gkalpakiotis S
Dermatol Ther; 2021 Jan; 34(1):e14708. PubMed ID: 33368910
[No Abstract] [Full Text] [Related]
24. Atopic dermatitis, dupilumab and cancers: a case series.
Siliquini N; Giura MT; Viola R; Ribero S; Panzone M; Dapavo P; Fierro MT; Ortoncelli M; Quaglino P
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e651-e652. PubMed ID: 33797094
[No Abstract] [Full Text] [Related]
25. Dupilumab for treatment of atopic dermatitis in patients living with HIV: a case series.
Nusbaum KB; Kaffenberger BH; Paradiso Bs MM; Sopkovich JA; Daou H; Seminario-Vidal L; Trinidad JC
Int J Dermatol; 2021 Sep; 60(9):e344-e346. PubMed ID: 33661522
[No Abstract] [Full Text] [Related]
26. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L
Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402
[TBL] [Abstract][Full Text] [Related]
27. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
Cork MJ; Eckert L; Simpson EL; Armstrong A; Barbarot S; Puig L; Girolomoni G; de Bruin-Weller M; Wollenberg A; Kataoka Y; Remitz A; Beissert S; Mastey V; Ardeleanu M; Chen Z; Gadkari A; Chao J
J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791
[No Abstract] [Full Text] [Related]
28. Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response.
Nettis E; Ferrucci SM; Pellacani G; Di Leo E; Argenziano G; Foti C; Rongioletti F; Patruno C; Ortoncelli M; Macchia L; Tavecchio S; Bonzano L; Di Bona D; Calabrese G; Fabbrocini G;
J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e896-e898. PubMed ID: 34310749
[No Abstract] [Full Text] [Related]
29. Dupilumab for atopic dermatitis: what are patients learning on YouTube?
Pithadia DJ; Reynolds KA; Lee EB; Wu JJ
J Dermatolog Treat; 2022 Feb; 33(1):571-572. PubMed ID: 32281445
[No Abstract] [Full Text] [Related]
30. Higher baseline serum lactate dehydrogenase level is associated with poor effectiveness of dupilumab in the long term in patients with atopic dermatitis.
Kato A; Kamata M; Ito M; Uchida H; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol; 2020 Sep; 47(9):1013-1019. PubMed ID: 32548920
[TBL] [Abstract][Full Text] [Related]
31. Dupilumab facial redness: Clinical characteristics and proposed treatment in a cohort.
Ordóñez-Rubiano MF; Casas M; Balaguera-Orjuela V
Dermatol Ther; 2021 Nov; 34(6):e15140. PubMed ID: 34549488
[TBL] [Abstract][Full Text] [Related]
32. Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated.
Sears AV; Woolf RT; Gribaleva E; Abdelrahman W; Robbie S; Menon B; Kirkham B; Smith CH; Pink AE
Br J Dermatol; 2021 Apr; 184(4):755-757. PubMed ID: 33107978
[No Abstract] [Full Text] [Related]
33. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
Hendricks AJ; Yosipovitch G; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
[No Abstract] [Full Text] [Related]
34. Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study.
Patruno C; Napolitano M; Argenziano G; Peris K; Ortoncelli M; Girolomoni G; Offidani A; Ferrucci SM; Amoruso GF; Rossi M; Stingeni L; Malara G; Grieco T; Foti C; Gattoni M; Loi C; Iannone M; Talamonti M; Stinco G; Rongioletti F; Pigatto PD; Cristaudo A; Nettis E; Corazza M; Guarneri F; Amerio P; Esposito M; Belloni Fortina A; Potenza C; Fabbrocini G;
J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):958-964. PubMed ID: 33332697
[TBL] [Abstract][Full Text] [Related]
35. Treatment of children from 6 to 11 years old affected by moderate-severe atopic dermatitis with dupilumab: a first perspective from a single-center real-life experience in Italy.
Colonna C; Zussino M; Monzani NA; Ponziani A; Cavalli R
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e478-e480. PubMed ID: 35067995
[No Abstract] [Full Text] [Related]
36. Diffuse erythema and peeling during dupilumab therapy in a patient with atopic dermatitis.
Cheng B; Yin M; Dou X
Dermatol Ther; 2021 Nov; 34(6):e15183. PubMed ID: 34716650
[No Abstract] [Full Text] [Related]
37. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort.
Faiz S; Giovannelli J; Podevin C; Jachiet M; Bouaziz JD; Reguiai Z; Nosbaum A; Lasek A; Ferrier le Bouedec MC; Du Thanh A; Raison-Peyron N; Tetart F; Duval-Modeste AB; Misery L; Aubin F; Dompmartin A; Morice C; Droitcourt C; Soria A; Arnault JP; Delaunay J; Mahé E; Richard MA; Schoeffler A; Lacour JP; Begon E; Walter-Lepage A; Dillies AS; Rappelle-Duruy S; Barete S; Bellon N; Bénéton N; Valois A; Barbarot S; Sénéchal J; Staumont-Sallé D;
J Am Acad Dermatol; 2019 Jul; 81(1):143-151. PubMed ID: 30825533
[TBL] [Abstract][Full Text] [Related]
38. A life with atopic dermatitis: the patient's point of view after a new hope with dupilumab.
D'Adamio S; Massaro A; Biocca S; Bianchi L; Talamonti M; Galluzzo M
Clin Exp Dermatol; 2020 Aug; 45(6):809-810. PubMed ID: 32472943
[No Abstract] [Full Text] [Related]
39. New-onset head and neck dermatitis in adolescent patients after dupilumab therapy for atopic dermatitis.
Bax CE; Khurana MC; Treat JR; Castelo-Soccio L; Rubin AI; McMahon PJ
Pediatr Dermatol; 2021 Mar; 38(2):390-394. PubMed ID: 33426747
[TBL] [Abstract][Full Text] [Related]
40. Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis.
Takeuchi S; Inoue K; Kuretake K; Kiyomatsu-Oda M; Furue M
J Dermatol; 2021 May; 48(5):638-644. PubMed ID: 33742710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
